ASH: PTLD Responds to Immunosuppression Cutback (CME/CE)

Courtesy MedPage Today Surgery  Thu, 12/10/2009 - 07:02

NEW ORLEANS (MedPage Today) -- Reducing immunosuppression offers a safe and effective strategy to manage post-transplantation lymphoproliferative disorder (PTLD) after solid-organ or stem-cell transplant, according to a study reported here.

Tags:

 

More related items

Stem Cell-Chemo Fails in Follicular Lymphoma (CME/CE)
(MedPage Today) -- For initial treatment of follicular lymphoma, high-dose chemotherapy with stem cell transplant support doesn't improve survival, a meta-analysis showed.

It's Okay to Ship Live-Donor Kidneys (CME/CE)
(MedPage Today) -- Transporting live-donor kidneys, sometimes over great distances, does not appear to have a negative effect on transplantation outcomes, researchers found.

Ablate and Wait in Liver CA, Experts Suggest (CME/CE)
(MedPage Today) -- Outcomes in all patients with hepatocellular carcinoma might improve with an "ablate-and-wait" strategy versus rapid transplantation, according to a group of clinicians who...

Country Save HE Laundry Detergent, Powder, 160-Load,...

Yogi Tea Calm, Bedtime, Tea Bags, 16-Count Boxes...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com